PRODUCT DETAILS

TRAJENTA 5 MG 10 TABLETS | Linagliptin for Type 2 Diabetes

TRAJENTA 5 MG 10 TABLETS contain Linagliptin 5 mg, a prescription DPP-4 inhibitor used with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.

TRAJENTA 5 MG 10 TABLETS

TRAJENTA 5 MG TABLETS (Linagliptin 5 mg): Comprehensive Guide and Benefits

Introduction to TRAJENTA 5 MG TABLETS

DPP-4 Inhibitor for Type 2 Diabetes Management

TRAJENTA 5 MG TABLETS contain Linagliptin 5 mg, an oral antidiabetic medicine belonging to the Dipeptidyl Peptidase-4 (DPP-4) inhibitor class. It is used to improve blood glucose control in adults with type 2 diabetes mellitus along with proper diet and exercise.

TRAJENTA may be prescribed alone when certain diabetes medicines are unsuitable or in combination with other antidiabetic therapies such as metformin, sulfonylureas, or insulin when additional glucose control is required.

Prescription Status: Prescription-only medicine.

Key Benefits of TRAJENTA 5 MG TABLETS

Helps improve blood sugar control in adults with type 2 diabetes.

Supports glucose regulation after meals.

Helps increase the body’s natural insulin response when blood glucose levels are elevated.

Can be used as monotherapy or combined with other diabetes medicines as prescribed.

Does not require dose adjustment in patients with kidney impairment in many cases. 

Composition

Active Ingredient:

Linagliptin – 5 mg

Dosage Form:

Oral Film-Coated Tablet

Drug Class:

DPP-4 (Dipeptidyl Peptidase-4) Inhibitor

Oral Antidiabetic Agent

Manufacturer/Marketer:

Boehringer Ingelheim India Pvt. Ltd. 

How TRAJENTA 5 MG Works

TRAJENTA contains Linagliptin, which blocks the activity of the DPP-4 enzyme. This increases the levels of incretin hormones such as GLP-1 and GIP, which help:

Increase insulin release when blood glucose levels are high.

Reduce glucagon secretion, a hormone that increases blood sugar.

Improve overall blood glucose regulation. 

Usage Instructions

Take TRAJENTA 5 MG TABLETS exactly as prescribed by your doctor.

The usual recommended dose is 5 mg once daily.

It may be taken with or without food.

Swallow the tablet whole with water.

Take it at the same time every day for consistent effect.

Do not stop treatment without medical advice. 

Medicinal Advantages

Type 2 Diabetes Management

Helps lower elevated blood glucose levels.

Supports improved glycemic control along with lifestyle modifications.

Combination Therapy Support

May be used with metformin, sulfonylureas, or insulin when additional glucose control is needed.

Kidney-Friendly Dosing

Linagliptin generally does not require dose adjustment in patients with renal impairment, making it a useful option for selected patients under medical supervision. 

Mechanism of Action

Linagliptin selectively inhibits the DPP-4 enzyme responsible for breaking down incretin hormones. By preserving incretin activity, it enhances glucose-dependent insulin secretion and decreases excess glucose production by reducing glucagon release.

Off-Label Uses

Healthcare professionals may evaluate Linagliptin-based therapy for conditions outside approved indications based on individual patient needs and clinical evidence.

Off-label use should only be considered under medical supervision.

Expert Advice

Follow a balanced diet and regular exercise plan along with TRAJENTA therapy.

Monitor blood glucose levels as advised by your doctor.

Inform your doctor if you have a history of pancreatitis.

Report severe abdominal pain, persistent nausea, or vomiting.

If used with insulin or sulfonylureas, monitor for symptoms of low blood sugar. 

Precautions

Pancreatitis Risk

Inform your doctor if you have previously experienced pancreatitis. Seek medical advice if you develop persistent severe abdominal pain.

Kidney Disease

Linagliptin may be used in patients with kidney impairment without routine dose adjustment, but medical supervision is recommended.

Liver Disease

Inform your healthcare provider about existing liver conditions before starting treatment.

Pregnancy and Breastfeeding

Consult your doctor before using TRAJENTA 5 MG during pregnancy or breastfeeding.

Drug Interactions

Inform your doctor if you are taking:

Insulin.

Sulfonylurea medicines.

Other antidiabetic medicines.

Medicines that affect liver enzyme activity.

Always provide a complete medication list to your healthcare provider.

Possible Side Effects

Common side effects may include:

Nasopharyngitis (cold-like symptoms).

Cough.

Headache.

Nausea.

Diarrhea.

Joint pain.

Hypoglycemia when combined with insulin or sulfonylureas. 

Seek medical attention for severe allergic reactions, breathing difficulty, or persistent abdominal pain.

Storage Instructions

Store below 30°C.

Keep tablets in the original packaging.

Protect from moisture and direct sunlight.

Keep out of reach of children.

Frequently Asked Questions (FAQs)

Q: What is TRAJENTA 5 MG used for?

A: TRAJENTA 5 MG is used to improve blood sugar control in adults with type 2 diabetes along with diet and exercise.

Q: What is the active ingredient in TRAJENTA 5 MG?

A: Each tablet contains Linagliptin 5 mg.

Q: Is TRAJENTA a type of insulin?

A: No. TRAJENTA is an oral DPP-4 inhibitor that helps the body regulate insulin response naturally.

Q: Can TRAJENTA be taken alone?

A: Yes, it may be used alone in selected patients or combined with other diabetes medicines as prescribed by a doctor.

Q: Does TRAJENTA cause low blood sugar?

A: TRAJENTA alone has a low risk of hypoglycemia, but the risk may increase when combined with insulin or sulfonylurea medicines.

Product Tags

TRAJENTA 5 MG 10 TABLETS, Linagliptin 5 mg Tablet, DPP-4 Inhibitor, Type 2 Diabetes Medicine, Blood Sugar Control Tablet, Oral Antidiabetic Medicine, Diabetes Management Tablet, Boehringer Ingelheim, Prescription Diabetes Medicine.